Intervention on gut microbiota may change the strategy for management of colorectal cancer

J Gastroenterol Hepatol. 2021 Jun;36(6):1508-1517. doi: 10.1111/jgh.15369. Epub 2021 Jan 5.

Abstract

Dysbiosis in the gut microbiota composition due to environmental or genetic variations can disrupt the immune system and may promote several diseases such as colorectal cancer (CRC). Gut microbiota can alter the toxicity and efficiency of an extensive range of CRC treatment methods, especially surgery, chemotherapy, radiotherapy, and immunotherapy. The recent scientific evidence suggested that gut microbiota modulation exhibits an essential positive influence on inhibition and treatment of CRC. The literature survey revealed that modulating the gut microbiota composition by probiotics, prebiotics, and diets protects CRC patients from treatment-associated adverse effects. This review summarizes the recent advancements in the association between interventions on gut microbiota and CRC to provide innovative strategies for enhancing the safety and efficiency of CRC therapy.

Keywords: Colorectal cancer; Diet; Gut microbiota; Interventions; Prebiotic; Probiotic.

Publication types

  • Review

MeSH terms

  • Colorectal Neoplasms / etiology
  • Colorectal Neoplasms / microbiology*
  • Colorectal Neoplasms / therapy*
  • Diet
  • Digestive System Surgical Procedures / methods
  • Drug Therapy / methods
  • Dysbiosis
  • Fecal Microbiota Transplantation
  • Female
  • Gastrointestinal Microbiome*
  • Humans
  • Immunotherapy / methods
  • Male
  • Prebiotics
  • Probiotics / therapeutic use
  • Radiotherapy

Substances

  • Prebiotics